Prof. Dr. Thomas Harrer



Organisation


Professur für Innere Medizin mit dem Schwerpunkt Immundefizienz


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 3 Go to next page Go to last page

Hecht, M., Harrer, T., Koeber, V., Sarpong, E.O., Moser, F., Fiebig, N.,... Distel, L. (2018). Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation. Oncology Letters, 15(2), 1728-1736. https://dx.doi.org/10.3892/ol.2017.7523
Lee, J.H., Ostalecki, C., Zhao, Z., Kesti, T., Bruns, H., Simon, B.,... Baur, A.S. (2018). HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles. EBioMedicine. https://dx.doi.org/10.1016/j.ebiom.2018.01.004
Kienhofer, D., Hahn, J., Stoof, J., Csepregi, J.Z., Reinwald, C., Urbonaviciute, V.,... Hoffmann, M. (2017). Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight, 2(10). https://dx.doi.org/10.1172/jci.insight.92920
Hahn, J., Kienhofer, D., Stoof, J., Csepregi, J.Z., Reinwald, C., Maueröder, C.,... Hoffmann, M. (2017). ROS is the boss. (pp. S17-S17).
Jackson, C.C., Best, L., Lorenzo, L., Casanova, J.-L., Wacker, J., Bertz, S.,... Harrer, T. (2016). A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression. Journal of Clinical Immunology, 36(1), 19-27. https://dx.doi.org/10.1007/s10875-015-0225-6
Lankes, K., Hundorfean, G., Harrer, T., Pommer, A.J., Agaimy, A., Angelovska, I.,... Heinzerling, L. (2016). Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis. OncoImmunology, 5(6), e1128611. https://dx.doi.org/10.1080/2162402X.2015.1128611
Borte, M., Krivan, G., Derfalvi, B., Marodi, L., Harrer, T., Jolles, S.,... Yel, L. (2016). Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies. Clinical and Experimental Immunology. https://dx.doi.org/10.1111/cei.12866
Lee, J.-H., Schierer, S., Blume, K., Dindorf, J., Wittki, S., Xiang, W.,... Baur, A. (2016). HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection. EBioMedicine, 6, 103-13. https://dx.doi.org/10.1016/j.ebiom.2016.03.004
Ostalecki, C., Wittki, S., Lee, J.-H., Geist, M.M., Tibroni, N., Harrer, T.,... Baur, A. (2016). HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection. EBioMedicine, 13, 294-304. https://dx.doi.org/10.1016/j.ebiom.2016.10.027
Wedmann, R., Onderka, C., Wei, S., Szijarto, I.A., Miljkovic, J., Mitrovic, A.,... Filipovic, M. (2016). Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. Chemical Science, 7(5), 3414-3426. https://dx.doi.org/10.1039/c5sc04818d

Last updated on 2016-05-05 at 05:10